Prevalence of amyloid blood clots in COVID-19 plasma

This paper discusses the common occurrence of clotting conditions (coagulopathies) that accompany COVID-19, especially micro-clots within the lungs. These clots are typically folded over protein (AKA amyloid) in nature as judged by a standard fluorogenic stain. The paper discusses more effective testing for identification of these clots. OF NOTE to the reader, we now know is the SPIKE PROTIEN causing this systemic response. It stands to reason that those who have received the COVID vaccines are therefore at elevated risk of amyloid clot formation given that their bodies are mass producing these same spike proteins throughout their bodies.

You may also like...

Popular Articles...

Leave a Reply

Your email address will not be published.